| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 140,435 | 112,077 | 110,388 | | Cost of Revenue | 50,837 | 40,423 | 32,370 | | | Gross Profit | 89,598 | 71,654 | 78,018 | | | Operating Expenses | | Research Development | 18,292 | 17,084 | 14,478 | | Selling General and Administrative | 81,243 | 76,618 | 71,082 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (9,937) | (22,048) | (7,542) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,708 | 3,690 | 3,081 | | Earnings Before Interest And Taxes | (7,229) | (18,358) | (4,461) | | Interest Expense | 12 | 7 | 17 | | Income Before Tax | (7,241) | (18,365) | (4,478) | | Income Tax Expense | 42 | 276 | 530 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,283) | (18,641) | (5,008) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,283) | (18,641) | (5,008) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,283) | ($18,641) | ($5,008) |
|
0.53% Nasdaq 
Income Statement
